Skip to main content
Journal cover image

Trends in Breast Cancer Treatment De-Implementation in Older Patients with Hormone Receptor-Positive Breast Cancer: A Mixed Methods Study.

Publication ,  Journal Article
Wang, T; Baskin, A; Miller, J; Metz, A; Matusko, N; Hughes, T; Sabel, M; Jeruss, JS; Dossett, LA
Published in: Ann Surg Oncol
February 2021

INTRODUCTION: Guidelines allow for the omission of sentinel lymph node biopsy (SLNB) and post-lumpectomy radiotherapy in women ≥ 70 years of age with hormone receptor-positive (HR +) breast cancer. Despite this, national data suggest these procedures have not been widely de-implemented. OBJECTIVES: Our objectives were to evaluate trends in SLNB and post-lumpectomy radiotherapy utilization in patients who are eligible for omission, and evaluate patient preferences as a target for de-implementation of low-value care. METHODS: We performed a sequential explanatory mixed-methods study by first analyzing an institutional database of patients ≥ 70 years of age with HR + breast cancer who received surgical treatment from 2014 to 2018. Based on the quantitative data, we conducted semi-structured interviews with women identified as high or low utilizers of breast cancer treatments to elicit patient perspectives on de-implementation. RESULTS: SLNB and post-lumpectomy radiotherapy were performed in 68% and 43% of patients, respectively, who met the criteria for omission. There was a significant decrease in SLNB rates from 2014 to 2018. Forty-nine percent of patients were classified as high utilizers and 26% were classified as low utilizers. Qualitative analysis found that the most important factors influencing decision making regarding SLNB and post-lumpectomy radiotherapy omission for both high and low utilizers were trust in their provider and a desire for peace of mind. CONCLUSIONS: Despite efforts to de-implement low-value care, older women with HR + breast cancer remain at risk of overtreatment. Patient perspectives suggest that multi-level de-implementation strategies will need to target provider practice patterns and patient-provider communication to promote high-quality decision making and reduction in breast cancer overtreatment.

Duke Scholars

Published In

Ann Surg Oncol

DOI

EISSN

1534-4681

Publication Date

February 2021

Volume

28

Issue

2

Start / End Page

902 / 913

Location

United States

Related Subject Headings

  • Sentinel Lymph Node Biopsy
  • Oncology & Carcinogenesis
  • Medical Overuse
  • Mastectomy, Segmental
  • Humans
  • Hormones
  • Female
  • Breast Neoplasms
  • Axilla
  • Aged
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Wang, T., Baskin, A., Miller, J., Metz, A., Matusko, N., Hughes, T., … Dossett, L. A. (2021). Trends in Breast Cancer Treatment De-Implementation in Older Patients with Hormone Receptor-Positive Breast Cancer: A Mixed Methods Study. Ann Surg Oncol, 28(2), 902–913. https://doi.org/10.1245/s10434-020-08823-w
Wang, Ton, Alison Baskin, Jacquelyn Miller, Allan Metz, Niki Matusko, Tasha Hughes, Michael Sabel, Jacqueline S. Jeruss, and Lesly A. Dossett. “Trends in Breast Cancer Treatment De-Implementation in Older Patients with Hormone Receptor-Positive Breast Cancer: A Mixed Methods Study.Ann Surg Oncol 28, no. 2 (February 2021): 902–13. https://doi.org/10.1245/s10434-020-08823-w.
Wang T, Baskin A, Miller J, Metz A, Matusko N, Hughes T, et al. Trends in Breast Cancer Treatment De-Implementation in Older Patients with Hormone Receptor-Positive Breast Cancer: A Mixed Methods Study. Ann Surg Oncol. 2021 Feb;28(2):902–13.
Wang, Ton, et al. “Trends in Breast Cancer Treatment De-Implementation in Older Patients with Hormone Receptor-Positive Breast Cancer: A Mixed Methods Study.Ann Surg Oncol, vol. 28, no. 2, Feb. 2021, pp. 902–13. Pubmed, doi:10.1245/s10434-020-08823-w.
Wang T, Baskin A, Miller J, Metz A, Matusko N, Hughes T, Sabel M, Jeruss JS, Dossett LA. Trends in Breast Cancer Treatment De-Implementation in Older Patients with Hormone Receptor-Positive Breast Cancer: A Mixed Methods Study. Ann Surg Oncol. 2021 Feb;28(2):902–913.
Journal cover image

Published In

Ann Surg Oncol

DOI

EISSN

1534-4681

Publication Date

February 2021

Volume

28

Issue

2

Start / End Page

902 / 913

Location

United States

Related Subject Headings

  • Sentinel Lymph Node Biopsy
  • Oncology & Carcinogenesis
  • Medical Overuse
  • Mastectomy, Segmental
  • Humans
  • Hormones
  • Female
  • Breast Neoplasms
  • Axilla
  • Aged